Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The objective of this study was to evaluate and compare the bioavailability and therefore to assess the bioequivalence of two different formulations of sitagliptin/metformin extended release tablets after a single oral dose administration under fed conditions.
Epistemonikos ID: ac537356e5a9c861c216524d8d1bfe0afa379273
First added on: May 15, 2024